Test early. Act sooner.
Siblings of children with autism are up to 7x more likely to receive an ASD diagnosis. ASD Insight from NeuroQure is a first-of-its-kind cellular biomarker test that detects autism risk as early as birth, giving families like yours the earliest possible window to intervene.
Watch this short video to see how ASD Insight™ works, why sibling risk is so significant, and how early detection changes outcomes for families navigating autism.
Research is clear: when a child has autism, their siblings carry significantly elevated risk. Early detection, before behavioral signs appear, opens the door to interventions that make a measurable difference.
Siblings of children with autism are 7x more likely to receive an autism diagnosis compared to the general population. The risk increases further with each additional affected sibling.
Traditional behavioral diagnosis typically cannot happen before 18 months. By then, critical early developmental windows may already be closing.
Studies consistently show that children who begin therapy before age 2 have significantly better language, social, and developmental outcomes.
A simple, science-backed process that gives your family clarity in weeks, not years.
Request ASD Insight™ through the NeuroQure website, which is then ordered by a healthcare provider for you.
A small skin sample is collected by a NeuroQure partner provider.
Simple results provided to you within weeks through our secure online portal.
Unlike behavioral screenings that require waiting, ASD Insight™ uses biological evidence to identify autism risk from the earliest days of life.
ASD Insight™ is particularly relevant for families who already have a child with autism. You already know the importance of early action. Now you have a tool to match.
Backed by 8+ years of peer-reviewed research, ASD Insight™ detects a functional biophysical marker (not behavior) to provide objective biological evidence of autism risk.
Traditional path diagnosis can take 2-4 years to get started. ASD Insight™ delivers risk insights in weeks, so your family can pursue early intervention without delay.
NeuroQure sends your test request to an independent telehealth provider to make the process seamless from start to finish.
ASD Insight™ can be requested for newborns and young infants, before any behavioral signs are observable. This is the earliest possible risk signal available today.
Developmental pediatricians and child neurologists use ASD Insight™ to have evidence-based conversations with families and to consider early intervention when it matters most.
If you have a child with autism, testing younger siblings now could be one of the most important decisions you make. ASD Insight™ gives your family the earliest possible window to act.